Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases
Euiheon Chung, Hiroshi Yamashita, Patrick Au et al. · 2009
Read Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases by Euiheon Chung, Hiroshi Yamashita, Patrick Au et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008316.txt.
Description
Euiheon Chung and colleagues built a way to track spreading cancer in a PLOS ONE paper from 2009. Few techniques can quantify systemic metastases in preclinical models. Metastases are tumors that colonize distant organs. Sensitive, real-time detection of that spread is urgently needed. The team engineered tumor cells to secrete Gaussia luciferase, a glowing enzyme.
The secreted marker reports tumor burden from a blood sample. Researchers could monitor progression and treatment response over time. Repeated measures in the same animal improve experiment quality. The biomarker approach may speed testing of anti-metastatic drugs.
Catalog record
| CREATOR | Euiheon Chung, Hiroshi Yamashita, Patrick Au et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008316